Cancer and Blood Specialty Clinic
Los Alamitos, California, United States
Oncologist in Los Alamitos, California
3851 Katella Ave #125, Los Alamitos, CA 90720
About Cancer and Blood Specialty Clinic
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Cancer and Blood Specialty Clinic
During the past decade, Cancer and Blood Specialty Clinic conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
2017-12-19
2024-06-30
Active, not recruiting
1,550
Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A
2018-03-16
2023-02-07
Terminated
1,382
Phase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
2019-07-15
2023-07-01
Active, not recruiting
532
Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss
2020-06-08
2024-06-19
Active, not recruiting
137
Trilaciclib, a CDK4/6 Inhibitor, in Patients With Early-Stage Triple Negative Breast Cancer
2021-11-19
2023-03-13
Completed
24
Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer
2022-03-11
2026-02-16
Recruiting
350
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)
2022-04-14
2027-10-01
Recruiting
900
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Cancer and Blood Specialty Clinic" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Novartis Pharmaceuticals" with 2 trials
sponsored, "Cardiff Oncology" with 1 trials sponsored, "Celcuity, Inc." with 1 trials sponsored and "G1 Therapeutics, Inc."
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer and Blood Specialty Clinic"
#1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Cancer and Blood Specialty Clinic
According to Clinical.Site data, the most researched conditions in "Cancer and Blood Specialty Clinic" are
"Breast Cancer" (2 trials), "Neoplasm Metastasis" (2 trials), "Triple Negative Breast Cancer" (2 trials), "Abiraterone Acetate" (1 trials) and "Androgens" (1 trials). Many other conditions were trialed in "Cancer and Blood Specialty Clinic" in a lesser frequency.
Clinical Trials Intervention Types at Cancer and Blood Specialty Clinic
Most popular intervention types in "Cancer and Blood Specialty Clinic" are "Drug" (11 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Abemaciclib" (2 trials), "Fulvestrant" (2 trials), "Abiraterone" (1 trials) and "Alpelisib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Cancer and Blood Specialty Clinic
The vast majority of trials in "Cancer and Blood Specialty Clinic" are
9 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Cancer and Blood Specialty Clinic
Currently, there are NaN active trials in "Cancer and Blood Specialty Clinic".
undefined are not yet recruiting,
6 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Cancer and Blood Specialty Clinic,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Cancer and Blood Specialty Clinic, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".